Geode Capital Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$505K Buy
221,522
+16,029
+8% +$46.5K ﹤0.01% 3580
2025
Q4
$658K Buy
205,493
+2,030
+1% +$5.09K ﹤0.01% 3504
2025
Q3
$511K Sell
203,463
-15,636
-7% -$48.4K ﹤0.01% 3610
2025
Q2
$728K Sell
219,099
-13,692
-6% -$48.8K ﹤0.01% 3432
2025
Q1
$976K Buy
232,791
+8,003
+4% +$36.4K ﹤0.01% 3311
2024
Q4
$1.08M Buy
224,788
+3,558
+2% +$16.7K ﹤0.01% 3346
2024
Q3
$814K Sell
221,230
-12,331
-5% -$43.7K ﹤0.01% 3424
2024
Q2
$946K Sell
233,561
-249,786
-52% -$1.07M ﹤0.01% 3328
2024
Q1
$2.32M Buy
483,347
+11,037
+2% +$64.2K ﹤0.01% 3060
2023
Q4
$3.57M Buy
472,310
+24,410
+5% +$200K ﹤0.01% 2869
2023
Q3
$4.59M Sell
447,900
-10,103
-2% -$125K ﹤0.01% 2682
2023
Q2
$6.32M Buy
458,003
+20,992
+5% +$315K ﹤0.01% 2567
2023
Q1
$7.1M Buy
437,011
+5,348
+1% +$101K ﹤0.01% 2467
2022
Q4
$7.64M Buy
431,663
+13,955
+3% +$277K ﹤0.01% 2435
2022
Q3
$8.15M Buy
417,708
+15,918
+4% +$338K ﹤0.01% 2384
2022
Q2
$8M Buy
401,790
+26,424
+7% +$590K ﹤0.01% 2414
2022
Q1
$9.68M Buy
375,366
+29,303
+8% +$760K ﹤0.01% 2363
2021
Q4
$8.74M Buy
346,063
+8,248
+2% +$228K ﹤0.01% 2549
2021
Q3
$9.08M Sell
337,815
-6,760
-2% -$195K ﹤0.01% 2521
2021
Q2
$11M Buy
344,575
+5,640
+2% +$179K ﹤0.01% 2394
2021
Q1
$11.9M Sell
338,935
-11,617
-3% -$404K ﹤0.01% 2247
2020
Q4
$11.2M Sell
350,552
-7,002
-2% -$216K ﹤0.01% 2088
2020
Q3
$11.3M Buy
357,554
+37,725
+12% +$1.25M ﹤0.01% 1871
2020
Q2
$11.4M Buy
319,829
+10,948
+4% +$380K ﹤0.01% 1855
2020
Q1
$8.89M Buy
308,881
+11,564
+4% +$303K ﹤0.01% 1803
2019
Q4
$6.99M Buy
297,317
+5,964
+2% +$134K ﹤0.01% 2253
2019
Q3
$5.25M Buy
291,353
+4,385
+2% +$72.4K ﹤0.01% 2355
2019
Q2
$4.5M Buy
286,968
+14,746
+5% +$290K ﹤0.01% 2466
2019
Q1
$6.2M Buy
272,222
+30,410
+13% +$686K ﹤0.01% 2210
2018
Q4
$5.62M Buy
241,812
+11,956
+5% +$319K ﹤0.01% 2147
2018
Q3
$7.59M Buy
229,856
+9,741
+4% +$364K ﹤0.01% 2106
2018
Q2
$9.7M Sell
220,115
-78,367
-26% -$3.03M ﹤0.01% 1885
2018
Q1
$12.5M Buy
298,482
+111,884
+60% +$5.17M ﹤0.01% 1606
2017
Q4
$8.49M Buy
186,598
+11,839
+7% +$466K ﹤0.01% 1859
2017
Q3
$5.79M Sell
174,759
-8,383
-5% -$341K ﹤0.01% 2108
2017
Q2
$7.43M Buy
183,142
+18,149
+11% +$562K ﹤0.01% 1867
2017
Q1
$3.32M Buy
164,993
+6,582
+4% +$139K ﹤0.01% 2364
2016
Q4
$3.65M Buy
158,411
+3,655
+2% +$78.3K ﹤0.01% 2263
2016
Q3
$3.14M Buy
154,756
+1,666
+1% +$33.6K ﹤0.01% 2267
2016
Q2
$2.87M Buy
153,090
+4,194
+3% +$77.1K ﹤0.01% 2240
2016
Q1
$2.67K Buy
148,896
+3,322
+2% +$56.9K ﹤0.01% 2256
2015
Q4
$2.5M Sell
145,574
-6,343
-4% -$107K ﹤0.01% 2318
2015
Q3
$2.44M Buy
151,917
+6,575
+5% +$110K ﹤0.01% 2307
2015
Q2
$2.51M Sell
145,342
-23,946
-14% -$402K ﹤0.01% 2350
2015
Q1
$2.8M Buy
169,288
+39,313
+30% +$609K ﹤0.01% 2226
2014
Q4
$1.87M Buy
129,975
+2,288
+2% +$30.8K ﹤0.01% 2476
2014
Q3
$1.74M Buy
127,687
+899
+0.7% +$12.5K ﹤0.01% 2441
2014
Q2
$1.71M Buy
126,788
+12,265
+11% +$162K ﹤0.01% 2473
2014
Q1
$1.53M Sell
114,523
-4,117
-3% -$57K ﹤0.01% 2505
2013
Q4
$1.97M Sell
118,640
-19,875
-14% -$310K ﹤0.01% 2298
2013
Q3
$2.26M Buy
138,515
+42,375
+44% +$661K ﹤0.01% 2100
2013
Q2
$1.21M Buy
+96,140
New +$1.25M ﹤0.01% 2355

Other funds holding PETS

Geode Capital Management's PETS Position: Q1 2026 in Review

Geode Capital Management increased its PetMed Express (PETS) stake by 7.8% in Q1 2026, buying an estimated $46.5K and bringing the position to 221,522 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #3580.

Geode Capital Management first reported a position in PETS in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.5M in Q1 2018. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • Geode Capital Management held 221,522 shares of PetMed Express worth $505K as of Q1 2026.
  • Geode Capital Management bought 16,029 PetMed Express shares in Q1 2026, an estimated $46.5K.
  • PetMed Express made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3580 holding.
  • Geode Capital Management first reported a position in PetMed Express in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's PetMed Express position peaked at $12.5M in Q1 2018.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.